SCHEMBL30433019

SCHEMBL30433019

COc1cc(=O)n2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.61
HPGD P15428 2/20 0.61
MAPT P10636 2/20 0.61
KMT2A Q03164 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
GRM5 P41594 2/20 0.54
ELANE P08246 1/20 0.48
ADORA3 P0DMS8 2/20 0.48
ADORA2A P29274 1/20 0.48
ADORA2B P29275 1/20 0.48
ADORA1 P30542 1/20 0.48
PRKDC P78527 1/20 0.48
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.44
NPC1 O15118 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
METTL3 Q86U44 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12442814 0.81 KDM4E (0.62) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL3963080 0.80 GRM5 (0.58) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL23414745 0.79 METTL3 (0.46) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL2823070 0.77 KDM4E (0.64) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL10440196 0.77 GRM5 (0.77) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL8108255 0.76 KDM4E (0.65) KDM4EMAPTKMT2ASMN1; SMN2ADORA2A
SCHEMBL7920089 0.76 HSP90AA1 (0.49) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL32688229 0.75 ALDH1A1 (0.50) KDM4EHPGDMAPTSMN1; SMN2HSD17B10
SCHEMBL3958034 0.75 KDM4E (0.55) KDM4EHPGDMAPTKMT2ASMN1; SMN2
SCHEMBL823315 0.75 ALDH1A1 (0.56) KDM4EHPGDMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDM4E 224/4885HPGD 1172/4885MAPT 4086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.